Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Feingold

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
The Journal of Biological Chemistry|June 5, 1989
Purification and characterization of guanosine diphospho-D-mannose dehydrogenase. A key enzyme in the biosynthesis of alginate by Pseudomonas aeruginosaS Roychoudhury, T B May, J F Gill, et al.
Infection and Immunity|January 1, 1979
Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophagesL A Glasgow, J L Crane, C J Schleupner, et al.
Cancer Treatment Reports|November 1, 1978
Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortusL A Glasgow, J L Crane, C J Schleupner, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Synthesis and antifungal properties of 14-aminomethyl-substituted lanosterol derivativesA B Cooper, J J Wright, A K Ganguly, et al.
The Journal of Clinical Investigation|March 1, 1975
Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patientsJ M Klick, G C du Moulin, J Hedley-Whyte, et al.
The New England Journal of Medicine|September 4, 1975
Aerosol polymyxin and pneumonia in seriously ill patientsT W Feeley, G C Du Moulin, J Hedley-Whyte, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Effects of topical erythromycin on ecology of aerobic cutaneous bacterial floraB R Vowels, D S Feingold, C Sloughfy, et al.
Journal of Clinical Microbiology|February 1, 1986
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin BD L Calhoun, G D Roberts, J N Galgiani, et al.
Journal of the American Academy of Dermatology|June 19, 1998
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenailR K Scher, D Breneman, P Rich, et al.
Journal of the American Academy of Dermatology|June 19, 1998
Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenailP Rich, R K Scher, D Breneman, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
The Journal of Biological Chemistry|June 5, 1989
Purification and characterization of guanosine diphospho-D-mannose dehydrogenase. A key enzyme in the biosynthesis of alginate by Pseudomonas aeruginosaS Roychoudhury, T B May, J F Gill, et al.
Infection and Immunity|January 1, 1979
Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophagesL A Glasgow, J L Crane, C J Schleupner, et al.
Cancer Treatment Reports|November 1, 1978
Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortusL A Glasgow, J L Crane, C J Schleupner, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Synthesis and antifungal properties of 14-aminomethyl-substituted lanosterol derivativesA B Cooper, J J Wright, A K Ganguly, et al.
The Journal of Clinical Investigation|March 1, 1975
Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. II. Effect on the incidence of pneumonia in seriously ill patientsJ M Klick, G C du Moulin, J Hedley-Whyte, et al.
The New England Journal of Medicine|September 4, 1975
Aerosol polymyxin and pneumonia in seriously ill patientsT W Feeley, G C Du Moulin, J Hedley-Whyte, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Effects of topical erythromycin on ecology of aerobic cutaneous bacterial floraB R Vowels, D S Feingold, C Sloughfy, et al.
Journal of Clinical Microbiology|February 1, 1986
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin BD L Calhoun, G D Roberts, J N Galgiani, et al.
Journal of the American Academy of Dermatology|June 19, 1998
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenailR K Scher, D Breneman, P Rich, et al.
Journal of the American Academy of Dermatology|June 19, 1998
Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenailP Rich, R K Scher, D Breneman, et al.
Pageof 11